Late Conversion From Calcineurin Inhibitor-Based to Sirolimus-Based Immunosuppression Due to Chronic Toxicity: A Prospective Study With Protocol Biopsy Amendment

USLU, A.; TÖZ, HÜSEYİN; ŞEN, SAİT; ALKAN, F.; NART, A.; AYKAS, A.; DOGAN, MEHMET; POSTACI, H.; SAHIN, T.; SIMSEK, C.

doi:10.1016/j.transproceed.2009.01.044

Late Conversion From Calcineurin Inhibitor-Based to Sirolimus-Based Immunosuppression Due to Chronic Toxicity: A Prospective Study With Protocol Biopsy Amendment

Atıf İçin Kopyala

USLU A., TÖZ H. , ŞEN S. , ALKAN F. T. , NART A., AYKAS A., ...Daha Fazla

TRANSPLANTATION PROCEEDINGS, cilt.41, ss.756-763, 2009 (SCI İndekslerine Giren Dergi)

Cilt numarası: 41 Konu: 2
Basım Tarihi: 2009
Doi Numarası: 10.1016/j.transproceed.2009.01.044
Dergi Adı: TRANSPLANTATION PROCEEDINGS
Sayfa Sayıları: ss.756-763

Özet

Background. There is an emerging consensus on conversion from calcineurin inhibitor (CNI)-based regimens to proliferation signal inhibitor (PSI)-based protocols for the prevention of a progressive decline in graft function due to CNI toxicity.